EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;34:181-186. doi:10.1016/j.ejcts.2008.03.059
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Franca M.A. Melfi
Marco Lucchi
Federico Davini
Alfredo Mussi
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Melfi, F. M.A.
Right arrow Articles by Mussi, A.
PubMed
Right arrow Articles by Melfi, F. M.A.
Right arrow Articles by Mussi, A.
Related Collections
Right arrow Lung - cancer

Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction

Franca M.A. Melfia,*, Marco Lucchia, Federico Davinia, Andrea Vitia, Gabriella Fontaninib, Laura Boldrinib, Giuseppe Bonic, Alfredo Mussia

a Division of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Italy
b Department of Surgery, University of Pisa, Italy
c Division of Nuclear Medicine, Department of Oncology, University of Pisa, Italy

Received 21 September 2007; received in revised form 18 February 2008; accepted 4 March 2008.

* Corresponding author. Tel.: +39 050 995211; fax: +39 050 9957239. (Email: f.melfi{at}med.unipi.it).

Objective: We previously reported the results achieved in detecting sentinel lymph nodes (SLN). We applied the molecular techniques (RT-PCR) to improve the detection of micrometastasis in order to evaluate an improvement of staging in early non-small cell lung cancer (NSCLC) patients (pts). Methods: This study was carried out on 22 consecutive NSCLC pts with stage I disease. A dose of 37 MBq (1 ml 99mTc-nanocolloid® suspension) was administered. The intralesional injection was performed under CT-guidance (7 pts), by using bronchoscopy (5 pts), VATS (2 pts) and at time of the thoracotomy (8 pts). RT-PCR analysis for cytokeratin 7 and 19 (CK7–CK19) was used to identify tumour-derived material in lymph nodes (LN). Each SLN was bisected: half was used for conventional examination (H&E staining/by immunohistochemistry (IHC), half was snap-frozen to –80 °C for RNA-detection of CK7 and CK19. Results: SLN was detected in 16 out of 19 pts. In three pts SLN was not identified (due to an incorrect technique). Conventional pathologic examination showed stage I disease in 13 pts, T3N0 disease in 1 pt, N2 in 5 pts. The IHC analysis identified micrometastasis in seven pts (two evaluated N0 according to H&E staining). RT-PCR analysis, performed in 10/16 pts, identified micrometastasis in 6 pts (3 pts evaluated N0 disease by H&E; 1 of these evaluated N0 even by IHC). All N2 patients relapsed. One patient (N0 pts after H&E and IHC analysis) with positive CK7 and CK19 expression by RT-PCR analysis relapsed (systemic relapse) 3 months after surgery. Conclusions: SLN technique could provide a subgroup of patients in which the use of RT-PCR could be applied on a well-focused target. This approach may be useful for stratifying histologically N0 patients into higher risk and lower risk groups.

Key Words: Lung cancer • Sentinel lymph node • Molecular staging • Cytokeratin 7 and 19







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.